Adam

The problem with Lyme disease is that there are no reliable tests, including the Western blot, that can immediately detect infection in its earliest stages. That delay matters. Early symptoms are often missed or dismissed, allowing the disease to progress and become much harder to treat. Now, with growing concerns about tick populations being introduced by our government and a new Lyme vaccine on the horizon from Pfizer, we are at a critical and potentially dangerous moment. Prevention cannot rely on awareness alone. We need to have serious conversations about access to prophylactic treatment after high-risk tick exposure. Early intervention could mean the difference between a short course of treatment and long-term, life-altering illness, ranging from neurological complications to severe reactions, including life-threatening anaphylaxis.